Open AccessPleuropulmonary lesions, ergotamines and asbestos exposure
Author(s) -
Gunnar Hillerdal,
Anna RaskAndersen
Publication year - 2005
Publication title -
scandinavian journal of work, environment and health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.621
H-Index - 103
eISSN - 1795-990X
pISSN - 0355-3140
DOI - 10.5271/sjweh.950
Subject(s) - asbestos , medicine , environmental health , dermatology , metallurgy , materials science
This study investigated the possibility of pleuropulmonary lesions, which can occur as rare but serious side effects of different ergot drugs, occurring more commonly in persons earlier exposed to asbestos.